[35] reported that a 6-month exenatide-based therapy produced a 42% relative reduction in intrahepatic lipid content, accompanied by a mean BW loss of 5 kg and significant decreases in both abdominal subcutaneous and visceral fat volumes
These changes mimic typical aging but happen suddenly in people who are still relatively young [6]
Discussion While GLP-1RAs hold considerable promise for ophthalmic disorders, particularly DR and glaucoma, significant hurdles remain in translating preclinical findings into routine clinical practice
SH: So instead of us getting into the weeds and getting stuck there, I can tell you as a patient, not as a doctor, but Im a patient too
Because this article has 8 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer
This route offers: Fast absorption into the bloodstream